Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

By R. Fox, David H. Miller, J. Phillips, M. Hutchinson, E. Havrdová, M. Kita, Minhua Yang, K. Raghupathi, M. Novas, M. Sweetser and 3 more. New England Journal of Medicine, 2012

1,326 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Pharmaceutical Science, Rheumatology

View Paper: https://www.semanticscholar.org/paper/a1786a5d0b580817b5f5790b597a31612d59ae1c